INTRODUCTION
In this paper, I will describe the development of a quality management program in an academic integrated delivery system, the University of Pennsylvania Health System (UPHS). The first part of this article describes the forces in American medicine that have allowed the quality management movement to develop and flourish. In addition, we will discuss the development process of an outcomes measurement system at the University of Pennsylvania and key issues that were faced when developing these systems. I decided to undertake this discussion since most outcomes programs have a great deal in common, and much can be learned by sharing experiences, although issues certainly vary with the local environment. The second part of this paper describes our transition from a hospital-based outcomes measurement effort to a program designed to cover an integrated delivery system. Quality assessment across the full continuum of care remains the next large challenge facing outcomes programs.
THE EARLY YEARS OF QUALITY MANAGEMENT
Five years ago, quality management was little more than a concept in American medicine. While there existed some early pioneers in health care quality, their following was not large, and their teachings for the most part went unheard.
There were many reasons for this late adoption of quality management by American medicine. First, the science of quality measurement was primitive in its early years. Data accuracy and reliability related to health care quality were criticized by traditionalists in medicine who had grown accustomed to applying strict scientific principles in interpretation of data. Early efforts at hospital-based outcomes measurement,, such as those initiated by the Hospital of the University of Pennsylvania in 1991, were perceived by those in mainstream medicine as well intentioned, but thought unlikely to have a significant impact on medical practice. Early outcomes work was seen as holding promise but was not viewed as a critical strategy in health care delivery. The common thinking was that the science of quality measurement had not come far enough to warrant the attention of either clinicians or health care managers.
Yet, during the last 5 years, the attitude toward quality management has undergone a dramatic transition in American medicine. Quality measurement and improvement have now risen to a much higher stature, and, in the case of some health care provider systems, have assumed a position at center stage in strategic planning. In other situations where quality measurement has not been fully embraced, its potential for impact has gained a healthy respect from providers.
Recalling my involvement in the early years of the field, I think it would be difficult to argue that this new acceptance of quality management has been the result of improved science in outcomes measurement. Rather, I believe that the bigger change has been the demand by payers to make health care providers accountable for outcomes. In the past several years, in particular, there has been growing assertiveness by American payers in demanding information on health care quality. Initially, these requests came from government agencies, from the managed care companies and, eventually, following the trend, have come from the national indemnity companies.
A PROVIDER'S RESPONSE TO PUBLIC ACCOUNTABILITY
This market-driven demand for health care quality data was not new to us at Penn. In 1989, the State of Pennsylvania, through a legislative mandate, required 172 D. J. Shulkin hospitals to report data on in-patient costs, length of stay, mortality and morbidity [1] . These data were then transformed into public documents (called 'Effectiveness Reports') that often became favored subjects for newspapers and television, as data comparisons between hospitals made interesting headline stories.
The response to public outcomes data has been far from consistent. Evaluation of these state-mandated initiatives by health care providers has demonstrated little acceptance of the value of these data. In a recent study, Schneider and Epstein reported that the majority of cardiovascular specialists believed that these data had little or no influence on their referral recommendations [2] . Most specialists felt that there was inadequate risk adjustment and the data provided were unreliable. Others who work closely with these data, including our group at Penn, have serious concerns about the severity adjusters used in the model employed by the State, as well as the adequacy of adjusters for referral patterns, such as inter-hospital patient transfers [3] . In addition, data supplied by hospitals may be easily manipulated by methods of hospital coding and by the thoroughness of chart documentation and laboratory and radiographic evaluations. Severity adjustments are also impacted by the use of specific clinical phrases used in documentation, which could allow for some gaming of the system, although there is no firm evidence that this is occurring.
Internal marketing studies at Penn confirmed that, even when data showed worse than expected outcomes in particular diagnoses and procedures, there was little impact on the public's perception of a hospital's position in delivering quality outcomes (W. Ferniany, personal communication). Patient market share data and referral patterns also have suggested little impact of public outcomes data [4, 5] . Hospital-based data are now readily accessible to companies wishing to purchase outcomes data through commercial sources at a relatively minor cost. Data maintained by the State of Pennsylvania suggest that the number of data requests by payers has substantially increased in the past several years. States other than Pennsylvania, such as Vermont, California, and Kentucky, have taken on public outcomes data collection initiatives [6] . However, it remains difficult to assess how this new source of outcomes data has been used by payers.
Even though it would be difficult to conclude that the effect of public outcomes data has been significant, its largest impact has most likely been on the psyche of the provider community. Public data on cost and quality fundamentally have demonstrated that outcomes data must be taken seriously. It has been a wake-up call for American medicine.
In the past 2 years we have seen this new acceptance of outcomes data evidenced in several ways. There has been an unparalleled interest in assessing clinical data and involvement in outcomes initiatives. Part of this interest may relate to the increasing requirement of many payers for review of a provider's outcomes data for consideration in their plans. Usual data requests include length of stay, mortality, complications, infections, costs, and the presence or absence of clinical protocols. Some managed care companies have also begun to tie financial incentives to documented improvement in quality and utilization. These programs work by placing a portion of the payment to the provider at risk, depending on the results of a year's worth of data related to quality and utilization.
Other reimbursement strategies used by payers have also had an impact on the internal use of quality and utilization data. First has been the intensifying pressure to reduce costs based upon the traditional hospital contracting strategies, which often reimburse providers with 'per diem' payments. Per diems are flat rate payments for each day that the patient remains in the hospital. As competitive pressures increase to reduce these rates, hospitals look for a corresponding way to reduce their daily costs for caring for patients. Second has been the newer market phenomenon of 'risk contracting', which allows the provider to accept a financial risk for a defined percentage of the premium from the managed care company. Risk contracting places the burden for outcomes and utilization on the provider, since it is now in their direct interest to provide the most efficient care with the fewest complications. These financial pressures have heightened the provider community's need to develop clinical resource management initiatives.
QUALITY MANAGEMENT AT THE UNIVERSITY OF PENNSYLVANIA
In the past, Penn's traditional academic structure has encouraged each academic department to have its own quality program. However, patients often do not receive clinical care within the confines of one clinical department. Instead, patients are likely to have an interchange between several departments across what has been termed a 'service line' (e.g. cardiovascular services and cancer services). Last year, Penn reorganized its quality program towards a service-line approach and away from the traditional departmentally-based model (Fig. 1) . Quality teams, composed of professionals from several academic departments and many disciplines, have now formed around service lines. For example, internists, surgeons, anesthesiologists, pathologists, nurses, physical therapists, and pharmacists are now all examining the same outcomes data and planning and implementing for quality improvement.
The implementation of the quality program at Penn has required several infrastructure changes in the hospital environment. One such change has been the redesign of the traditional quality measurement programs at Penn. The traditional quality department (called the Department of Quality Assessment) now focuses on the development of outcomes measures and reporting of the data throughout the institution. The department had to reprogram its databases and reports to support data requirements for the new service-line approach to quality assessment. The primary responsibility of quality assessment staff is now to analyse data, prioritize improvement needs, and facilitate quality improvement teams. Data collection, staffing of meetings, and preparation for JCAHO accreditation visits have been de-emphasized from a primary responsibility for this department. Another change in structure for the quality program has been the development of the Clinical Resource Management Program (CRMP). The CRMP was designed to bring case-management services to the hospital environment and, as a result, to improve quality and reduce costs. Bringing this about required a redesign of the functions of utilization review staff, discharge planners, social workers, and the quality assurance analysts. The new role of the clinical resource coordinator was created for close monitoring of a specified set of patients. The clinical resource coordinator duties include collection of concurrent outcomes data, providing interventions to improve quality and efficiency, and interaction directly with payers. A third change in the structure of the quality organization was the development of a Critical Pathways and Quality Systems Office. This office was developed and staffed with professionals dedicated to building the infrastructure required to support implementation of critical pathways and practice guidelines. To date, over 50 critical pathways are being developed, and approximately 20 have been implemented in the hospital environment. Approximately 20 practice guidelines have also been integrated into clinical practice. The Office of Critical Pathways and Quality Systems is also responsible for oversight and dissemination of functional status assessment measurement initiatives and risk assessment strategies. The new structure of a redesigned quality organization, development of pathways and guidelines, and implementation of the CRMP has allowed for many success stories in cost reduction and quality improvement. Pathways at Penn, as in many other centers, have been found to facilitate reductions in length of stay and ancillary test use [7] . However, of greater significance has been the impact on improving outcomes as a result of pathway use. One example has been the redesign of extubation practices in cardiac bypass surgery patients, a result of the pathway initiative (Fig. 2) . The impact has been a reduction in adverse bleeding and a resulting decrease in transfusion costs. 
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resource management at Penn has been the development of an antibiotic management program. This program, run by an infectious disease physician and a pharmacist has shown impressive results in improving the rate of appropriate antibiotic ordering, which has resulted in decreased antibiotic costs (Fig. 3) .
Compliance with clinical resource initiatives and quality management activities is one of the major issues faced by health care organizations that have engaged in these endeavors. At Penn, we have devoted a great deal of effort to providing clinicians with clinically meaningful data about their practices compared to those of their peers. This is accomplished by providing both department-and physician-specific profiles, which detail patient demographics in their practice, mortality and morbidity rates, length of stay, costs, patient satisfaction, and other available outcomes data. In addition, data are presented from other major academic centers and other hospitals in the Philadelphia region. These bench-mark data have been an essential component of our outcomes management program. Currently, Penn participates in several data-sharing initiatives, including the University Health System Consortium Clinical Information Network, the American Association of Medical College's comparative database, and a commercially available outcomes system developed by Care Management Sciences Corporation.
EXPANSION OF THE QUALITY PROGRAM INTO THE HEALTH SYSTEM
In 1993, the University of Pennsylvania formally developed a health system structure that now includes the Hospital of the University of Pennsylvania and other owned and affiliated hospitals, the School of Medicine, the faculty practice plan, a primary care physician organization, a management services organization, long-term care facilities, a home health care organization, and rehabilitation and psychiatric care facilities.
Expansion of the quality management initiatives out of the hospital setting and into the broader health system was required as the emphasis in health care began to shift away from solely an in-patient focus. One of the first steps in the expansion of the quality program was the appointment of the Chief Quality Officer. The role of the Chief Quality Officer was to be responsible for the oversight and implementation of clinical management strategies and quality measurement activities. This position and resulting infrastructure, including the creation of a position called Senior Director of Quality and designed to coordinate initiatives, have allowed the system to respond appropriately to the needs of the overall health system and avoid duplication of efforts among the various entities of the system (Fig. 3) . A new quality-related committee structure was designed to coordinate quality and outcomes data across the system (Fig. 4) . These committees divide quality reporting into activities based at the main medical center campus, including those based in the faculty practice plan, regional quality activities involving the ambulatory care-based primary care physicians, and institutionbased quality activities involving other hospitals, longterm care, and other Penn health system facilities. The coordination of overall health system activities is provided at the Quality Oversight Committee, which meets three times a year.
FUTURE ISSUES IN QUALITY MEASUREMENT AND MANAGEMENT
The ability to track patient outcomes across the continuum of care is currently a challenge for quality planners. This involves measurement of outcomes for an episode of care and designing care for specific patient populations or disease categories (a field now referred to as 'disease management' or 'total health management'). At Penn, we have recently organized Penn Health Management, a new initiative devoted specifically to develop disease management programs for patients within our health system. Disease management requires the ability to integrate primary and specialty care quality measures in order to track outcomes across the continuum of care. Integrated delivery systems, such as the one at Penn, are rapidly moving towards an operational quality program that can meet these requirements.
Future issues in quality measurement will focus on developing plans for clinical strategies and compliance with these protocols. Feedback of clinical information and reporting variances from these protocols will continue to be important strategies. Additional opportunities for quality improvement may be implemented by those systems that have the ability to link financial and non-financial incentives with outcomes, cost, and satisfaction data.
Pressure will remain for provider systems to reduce costs. There will also be competitive advantages for systems that develop effective means to improve efficiency, while maintaining or improving quality. Quality measurement and management programs will likely play an increasingly important role in the future evolution of integrated delivery systems.
